Posted: October 20th, 2020
Conversant v. Huawei – UK Court of Appeal finds patent invalid for added matter This was an appeal from a decision of one of the two technical trials in the FRAND dispute between Conversant and Huawei playing out in the Courts of the UK, Germany and China. The patent in suit was European Patent (UK) […]
READ MORE
Posted: October 16th, 2020
Menzis Zorgverzekeraar N.V. and AnderZorg N.V. v. AstraZeneca B.V. and AstraZeneca AB, District Court The Hague 14 October 2020, Case no. C/09/541261 / HA-ZA 17-1084 On the 14th of October 2020 the Dutch District Court of The Hague has issued a noteworthy and ground breaking interlocutory judgment in the case of health insurance company Menzis […]
READ MORE
Posted: October 15th, 2020
Novartis v. Mylan (deferasirox) District Court of The Hague (PI judge Brinkman), 29 September 2020, KG ZA 20-605 Facts The patentee Novartis AG (“Novartis”) is the proprietor of EP 0 914 118 (“EP 118”). EP 118 covers deferasirox, an oral iron chelator that is sold by Novartis under the trademark Exjade. EP 118 is granted […]
READ MORE
Posted: October 15th, 2020
Ciel et Terre International versus Profloating, PI judge of the District Court of The Hague 6 October 2020, ECLI:NL:RBDHA:2020:9924 Facts Ciel et Terre International (hereinafter: “C&T”) is the owner of European patent EP 3 336 447 B1 (hereinafter: “EP ‘447”), which relates to a floating photovoltaic installation comprising photovoltaic panels and two types of modular […]
READ MORE
Posted: October 14th, 2020
With its decision no. 1094 of 14th May 2020, the Court of Appeal of Milan issued a ruling on the recovery of profits from the patent infringer, one of the most debated topics of the Italian legislation on Industrial and Intellectual property rights. The case at stake concerned Cama 1 S.p.A. (“Cama”), a packaging company, […]
READ MORE
Posted: October 13th, 2020
General Assembly and Annual Congress – 4 December In the light of the ongoing pandemic, the EPLAW Board has taken the difficult decision not to hold an in-person General Assembly and Annual Congress this year. Instead, the General Assembly and Annual Conference will be held online in a closed virtual space. The online meeting will […]
READ MORE
Posted: October 8th, 2020
Yesterday, EPLAW held its first member driven knowledge webinar. The session lasted one hour and centred around a panel discussion of recent learnings from remote hearings in a number of jurisdictions. Approximately fourty EPLAW members participated. Moderator Myles Jelf guided panelists Tess Waldron, Kristof Neefs, Tilman Müller-Stoy, Fabrizio Jacobacci and Mike Gilbert through various topics […]
READ MORE
Posted: October 5th, 2020
Nokia v. Daimler, District Court of Mannheim, dec. of August 18, 2020, case docket 2 O 34/19 On August 18, 2020, the District Court of Mannheim handed down the first judgment in the current litigation campaign of Nokia v. Daimler. Despite Daimler’s FRAND defense, the Court enjoined Daimler from using a certain technology in Daimler […]
READ MORE
Posted: October 2nd, 2020
Lacosamide / Commercial Court no. 5 of Barcelona, 14 April 2020, Docket No. 672/2017 / Invalidity action (public availability of a prior art document) & action for threat of patent infringement On 8 September 2017 the plaintiff, LABORATORIOS NORMON, S.A. (hereinafter, “NORMON”) filed an invalidity action against the companies RESEARCH CORPORATION TECHNOLOGIES INC., UCB BIOPHARMA […]
READ MORE
Posted: September 26th, 2020
Eli Lilly and Company and Lilly France v. Fresenius Kabi France and Fresenius Kabi Groupe France, Judiciary Court of Paris, France, 11 September 2020, Docket № 17/10421, by Pierre Véron, Honorary President, EPLAW Joining a majority of European Courts, the Paris court has held that Eli Lilly’s patent, claiming the combined administration of pemetrexed disodium […]
READ MORE
EMAIL US
